Table 2. Details of patients being considered for radical treatment for oesophageal or oesophago-gastric cancer at a specialist MDT.
| All patients (n=240) | |
|---|---|
| Mean age at diagnosis (s.d.), years | 65.0 (9.4) |
| Male (%) |
179 (74.6) |
|
Histological tumour type (%) | |
| Adenocarcinoma | 169 (70.4) |
| Squamous cell carcinoma | 66 (27.5) |
| Other cell type | 1 (0.4) |
| Unknown |
4 (1.7) |
|
Staging investigations performed (%) | |
| CTS | 240 (100.0) |
| PET-CT | 238 (99.2) |
| EUS | 194 (80.8) |
| Staging laparoscopy |
52 (21.7) |
| Eventual radical treatment (%) |
139 (57.9) |
| Oesophagectomy | 84 (60.4) |
| Gastrectomy | 10 (7.2) |
| Definitive chemoradiotherapy | 31 (22.3) |
| Other |
14 (10.1) |
|
If surgical treatment (%) | |
| Neoadjuvant chemotherapy | 81 (86.2) |
Abbreviations: CTS=computerised tomography; EUS=endoscopic ultrasound; MDT=multi-disciplinary team; PET-CT=positron emission tomography-computed tomography.